ATE154237T1 - Inhalationspulver enthaltend antistatisches hilfsmittel - Google Patents

Inhalationspulver enthaltend antistatisches hilfsmittel

Info

Publication number
ATE154237T1
ATE154237T1 AT93918018T AT93918018T ATE154237T1 AT E154237 T1 ATE154237 T1 AT E154237T1 AT 93918018 T AT93918018 T AT 93918018T AT 93918018 T AT93918018 T AT 93918018T AT E154237 T1 ATE154237 T1 AT E154237T1
Authority
AT
Austria
Prior art keywords
powder containing
inhalation powder
containing antistatic
antistatic aid
aid
Prior art date
Application number
AT93918018T
Other languages
English (en)
Inventor
Gordon Thomas Rhone-Po Simpkin
Roy Rhone-Poulenc Rore Trunley
Ann-Marie Rhone-Poule Leighton
Original Assignee
Rhone Poulenc Rorer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Ltd filed Critical Rhone Poulenc Rorer Ltd
Application granted granted Critical
Publication of ATE154237T1 publication Critical patent/ATE154237T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT93918018T 1992-08-14 1993-08-13 Inhalationspulver enthaltend antistatisches hilfsmittel ATE154237T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9217312A GB2269992A (en) 1992-08-14 1992-08-14 Powder inhalation formulations

Publications (1)

Publication Number Publication Date
ATE154237T1 true ATE154237T1 (de) 1997-06-15

Family

ID=10720370

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93918018T ATE154237T1 (de) 1992-08-14 1993-08-13 Inhalationspulver enthaltend antistatisches hilfsmittel

Country Status (16)

Country Link
US (1) US5908639A (de)
EP (1) EP0654991B1 (de)
JP (1) JP3787573B2 (de)
AT (1) ATE154237T1 (de)
AU (1) AU678379B2 (de)
CA (1) CA2142126C (de)
DE (1) DE69311556T2 (de)
DK (1) DK0654991T3 (de)
ES (1) ES2106362T3 (de)
GB (1) GB2269992A (de)
GR (1) GR3024468T3 (de)
IL (1) IL106665A (de)
MX (1) MX9304975A (de)
NZ (1) NZ254945A (de)
WO (1) WO1994004133A1 (de)
ZA (1) ZA935943B (de)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
US5612053A (en) * 1995-04-07 1997-03-18 Edward Mendell Co., Inc. Controlled release insufflation carrier for medicaments
GB9515182D0 (en) 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
US6017963A (en) * 1995-11-14 2000-01-25 Euro-Celtique, S.A. Formulation for intranasal administration
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US20020052310A1 (en) 1997-09-15 2002-05-02 Massachusetts Institute Of Technology The Penn State Research Foundation Particles for inhalation having sustained release properties
US5871010A (en) * 1996-06-10 1999-02-16 Sarnoff Corporation Inhaler apparatus with modified surfaces for enhanced release of dry powders
FR2756739B1 (fr) * 1996-12-05 2000-04-28 Astra Ab Nouvelle formulation de budesonide
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
JP2001514663A (ja) 1997-03-12 2001-09-11 エスモンド，ロバート ダブリュー． アルツハイマー病を処置または予防するための方法
US7052678B2 (en) 1997-09-15 2006-05-30 Massachusetts Institute Of Technology Particles for inhalation having sustained release properties
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
US6191154B1 (en) 1998-11-27 2001-02-20 Case Western Reserve University Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
CA2387212A1 (en) * 1999-10-12 2001-04-19 Kaken Pharmaceutical Co., Ltd. Dry powder inhalation and a method for the preparation thereof
CN1188111C (zh) * 1999-10-29 2005-02-09 耐科塔医药公司 分散性得到改进的干粉组合物
WO2001056581A1 (en) * 2000-02-04 2001-08-09 Kissei Pharmaceutical Co., Ltd. Powdered preparation for inhalation and powder inhalant containing the same packed
HUP0300491A2 (en) 2000-02-28 2003-07-28 Vectura Ltd Improvements in or relating to the delivery of oral drugs
PE20011227A1 (es) 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
IL153705A0 (en) * 2000-06-27 2003-07-06 Vectura Ltd Method of making particles for use in a pharmaceutical composition
CA2413692C (en) * 2000-06-27 2011-10-18 Vectura Limited Method of making particles for use in a pharmaceutical composition
EP1337239B2 (de) * 2000-11-30 2015-11-25 Vectura Limited Partikel zur verwendung in einer pharmazeutischen zusammensetzung
ES2587135T3 (es) 2000-11-30 2016-10-20 Vectura Limited Procedimiento de fabricación de partículas para su uso en una composición farmacéutica
AU2002230993B2 (en) 2000-12-29 2006-02-02 Alkermes, Inc. Particles for inhalation having sustained release properties
WO2003020197A1 (en) 2001-09-05 2003-03-13 Vectura Limited Improvements in or relating to the delivery of oral drugs
WO2003043585A2 (en) 2001-11-20 2003-05-30 Advanced Inhalation Research, Inc. Improved particulate compositions for pulmonary delivery
JP2005514393A (ja) 2001-12-19 2005-05-19 ネクター セラピューティクス アミノグリコシドの肺への供給
JP2005527508A (ja) 2002-03-07 2005-09-15 ヴェクトゥラ　リミテッド 経口デリバリー用急速溶融多粒子製剤
WO2003080149A2 (en) 2002-03-20 2003-10-02 Mannkind Corporation Inhalation apparatus
US7638138B2 (en) 2003-02-21 2009-12-29 Translational Research, Ltd. Compositions for nasal administration of pharmaceuticals
USRE45404E1 (en) 2003-03-27 2015-03-03 Shin Nippon Biomedical Laboratories, Ltd. Powder medicine applicator for nasal cavity
ITMI20040795A1 (it) * 2004-04-23 2004-07-23 Eratech S R L Composizione farmaceutica solida secca suo processo di preparazione e sospensione acquosa stabile ottenuta dalla stessa
US8673360B2 (en) 2004-08-10 2014-03-18 Shin Nippon Biomedical Laboratories, Ltd. Compositions that enable rapid-acting and highly absorptive intranasal administration
ATE486064T1 (de) 2004-08-20 2010-11-15 Mannkind Corp Katalyse der diketopiperazinsynthese
HUE025151T2 (en) 2004-08-23 2016-01-28 Mannkind Corp Diceto-piperazine salts for drug delivery
EP1657278A1 (de) 2004-11-12 2006-05-17 SOLVAY (Société Anonyme) Beschichtete Calciumcarbonat-Teilchen mit grosser spezifischer Oberfläche
KR101486397B1 (ko) 2005-09-14 2015-01-28 맨카인드 코포레이션 활성제에 대한 결정질 미립자 표면의 친화력의 증가를 기반으로 하는 약물 제제화의 방법
US20070172430A1 (en) * 2006-01-20 2007-07-26 Nastech Pharmaceutical Company Inc. Dry powder compositions for rna influenza therapeutics
KR20080096809A (ko) 2006-02-22 2008-11-03 맨카인드 코포레이션 디케토피페라진 및 활성제를 포함하는 마이크로입자의 약학특성의 개선 방법
CN101668544B (zh) 2006-12-26 2013-04-24 株式会社新日本科学 经鼻投用制剂
ES2929343T3 (es) 2008-06-13 2022-11-28 Mannkind Corp Inhalador de polvo seco accionado por aspiración para la administración de fármacos
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
MX2010014240A (es) 2008-06-20 2011-03-25 Mankind Corp Un metodo y aparato interactivo para perfilar en tiempo real esfuerzos de inhalacion.
EP2321023B1 (de) * 2008-07-18 2016-06-15 Prosonix Limited Verfahren zur erhöhung der kristallinität von fluticasonteilchen
TWI494123B (zh) 2008-08-11 2015-08-01 Mannkind Corp 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
PL3578169T3 (pl) 2009-02-26 2024-09-02 Glaxo Group Limited Preparaty farmaceutyczne zawierające 4-{(1r)-2-[(6-{2-[(2,6-dichlorobenzylo)oksy]etoksy}heksylo)amino]-1-hydroksyetylo}-2-(hydroksymetylo)fenol
WO2010105094A1 (en) 2009-03-11 2010-09-16 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
JP2012526726A (ja) 2009-05-15 2012-11-01 株式会社新日本科学 薬物動態が改善された鼻腔内用薬学的組成物
MY157166A (en) 2009-06-12 2016-05-13 Mankind Corp Diketopiperazine microparticles with defined specific surface areas
WO2011013003A2 (en) 2009-07-31 2011-02-03 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
WO2011056889A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
BR112012033060A2 (pt) 2010-06-21 2018-02-27 Mannkind Corp métodos de sistema de liberação de fármaco em pó seco
AU2012236150B2 (en) 2011-04-01 2016-03-31 Mannkind Corporation Blister package for pharmaceutical cartridges
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
BR112014009686A2 (pt) 2011-10-24 2018-08-07 Mannkind Corp composição analgésica inalável, pó seco e método para tratar dor
AU2013289957B2 (en) 2012-07-12 2017-02-23 Mannkind Corporation Dry powder drug delivery systems and methods
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
KR102246914B1 (ko) 2013-03-15 2021-04-30 맨카인드 코포레이션 미세결정성 디케토피페라진 조성물 및 방법
CN114848614A (zh) 2013-07-18 2022-08-05 曼金德公司 热稳定性干粉药物组合物和方法
EP3030294B1 (de) 2013-08-05 2020-10-07 MannKind Corporation Insufflationsvorrichtung
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
TW202210072A (zh) 2020-05-26 2022-03-16 美商羅德科技公司 用於鼻內或吸入遞送之大麻素組合物及劑型
JP7606825B2 (ja) * 2020-06-15 2024-12-26 東和薬品株式会社 エソメプラゾール顆粒ならびにその製造方法および用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4581225A (en) * 1984-04-25 1986-04-08 Eli Lilly And Company Sustained release intranasal formulation and method of use thereof
US4916230A (en) * 1984-07-02 1990-04-10 Merck & Co., Inc. Process for preparing novel N-(acyloxy-alkoxy)carbonyl derivatives useful as bioreversible prodrug moieties for primary and secondary amine functions in drugs
JP2770970B2 (ja) * 1987-04-09 1998-07-02 フアイソンズ・ピーエルシー ペンタミジンを含有する医薬組成物
US5039699A (en) * 1989-03-27 1991-08-13 Lederle (Japan), Ltd. Anti-peptic ulcer agent
JPH05963A (ja) * 1990-04-13 1993-01-08 Toray Ind Inc ポリペプチド類組成物
GB9020544D0 (en) * 1990-09-20 1990-10-31 Sandoz Ltd Improvements in or relating to organic compounds
IE71647B1 (en) * 1991-01-28 1997-02-26 Rhone Poulenc Rorer Ltd Benzamide derivatives

Also Published As

Publication number Publication date
DK0654991T3 (da) 1997-12-29
AU4725693A (en) 1994-03-15
IL106665A (en) 1998-02-22
GB2269992A (en) 1994-03-02
CA2142126C (en) 2007-01-09
JPH08500109A (ja) 1996-01-09
EP0654991A1 (de) 1995-05-31
ZA935943B (en) 1994-06-09
DE69311556D1 (de) 1997-07-17
CA2142126A1 (en) 1994-03-03
GB9217312D0 (en) 1992-09-30
US5908639A (en) 1999-06-01
ES2106362T3 (es) 1997-11-01
IL106665A0 (en) 1993-12-08
NZ254945A (en) 1996-06-25
MX9304975A (es) 1994-05-31
GR3024468T3 (en) 1997-11-28
WO1994004133A1 (en) 1994-03-03
JP3787573B2 (ja) 2006-06-21
EP0654991B1 (de) 1997-06-11
AU678379B2 (en) 1997-05-29
DE69311556T2 (de) 1997-12-04

Similar Documents

Publication Publication Date Title
DK0654991T3 (da) Inhalationspulver indeholdende antistatisk hjælpemiddel
DE69417232D1 (de) Intravaginales wirkstoffabgabesystem
FI954098A0 (fi) Kuivajauheen inhalaattorin lääkeaineen kantolaite
ES2128411T3 (es) Inhalador de polvo con soportes de polvo con microestructuras regulares.
NO911260D0 (no) Utleveringssystem for aromastoff og soetningsmiddel, samt fremgangsmaate for fremstilling av et slikt system.
AU645342B2 (en) Antimicrobial peptides and an antimicrobial agent
FI952976A7 (fi) Inhalaattori jauhemaisia lääkkeitä varten
PL341054A1 (en) Novel suppositiories containing an active compound being unstable in acid environments
NZ237790A (en) Substituted benzimidazoles and medicaments.
FI954989A0 (fi) Lääkelaastari
MY131774A (en) Coated pesticidal agents, processes for their preparation and compositions containing them
BG103677A (en) Solid mixtures based on sulphonylcarbamides and adjuvants
HU904007D0 (en) Medical preparations providing regulated active agent discharge and processes for the preparation thereof
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
ZA852495B (en) Anticonvulsant agents
NO985079L (no) Eksplosiv formulering
AU7467994A (en) Novel polysaccharide and radioprotective agent containing the same as active ingredient
GB9312982D0 (en) Active agent delivery systems
HUT67313A (en) Process for prepg. new bacis ethers and pharmaceutical compn.s containing them
GB9010570D0 (en) Agent,and method,for preventing drift of dust
SG34313A1 (en) Tape carrying active agent-containing fine powder
NL193772B (nl) Drager voor gevogelte en pluimvee.
ZA917367B (en) Pharmacologically active compounds and use.
GB9315411D0 (en) Active agent delivery
BG101119A (en) Analgesic composition

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner